Burning Rock Biotech (BNR) Other Non-Current Liabilities (2019 - 2026)

Burning Rock Biotech's Other Non-Current Liabilities history runs 8 years deep, the most recent figure standing at $1.7 million for Q1 2026.

• In Q1 2026, Other Non-Current Liabilities rose 18.2% year-over-year to $1.7 million; the TTM figure through Mar 2026 stood at $1.7 million (up 18.2% YoY), while the FY2025 annual figure was $1.7 million, up 19.89% from the prior year.
• Other Non-Current Liabilities for Q1 2026 stood at $1.7 million, up from $1.7 million in the prior quarter.
• The five-year high for Other Non-Current Liabilities was $6.5 million in Q3 2022, with the low at $416000.0 in Q2 2023.
• The 5-year median for Other Non-Current Liabilities is $1.5 million (2024), against an average of $1.6 million.
• The sharpest annual moves came in 2022 and 2023: Other Non-Current Liabilities soared 18408.57% in 2022, then plunged 92.67% in 2023.
• Burning Rock Biotech's Other Non-Current Liabilities stood at $579851.2 in 2022, then grew by 8.67% to $630132.1 in 2023, then jumped by 130.32% to $1.5 million in 2024, then climbed by 16.33% to $1.7 million in 2025, then gained by 2.7% to $1.7 million in 2026.
• Business Quant data shows BNR's Other Non-Current Liabilities at $1.7 million in Q1 2026, $1.7 million in Q4 2025, and $1.6 million in Q3 2025.